Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GENERAL ELECTRIC COMPANY

(GE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

General Electric : GE Healthcare Receives FDA Clearance of the Industry's First Contrast-Enhanced Mammography Solution for Biopsy

06/10/2020 | 05:37am EDT

Chicago, Illinois -- To help empower clinicians and patients in their fight against breast cancer, GE Healthcare today announced the Food and Drug Administration's 510(k) clearance of Pristina Serena Bright(TM)*, the healthcare industry's first contrast-enhanced mammography solution for biopsy.

The clearance comes at a time when women's health clinics worldwide begin to reopen and are managing new protocols to help reduce staff and patient exposure to COVID-19. In the United States alone, breast cancer screenings experienced more than a 90% decline due to the pandemic.[1]

Accordingly, the Society of Breast Imaging has recommended providers consider the use of abbreviated breast procedures to reduce the time a patient is in the clinic and reduce staff to only essential employees.[2]

With Pristina Serena Bright, breast biopsy exams can now be done with the same mammography equipment, with the same staff, and in the same room as the screening or diagnostic mammogram. Previously, for lesions not seen on mammography or ultrasound, contrast-enhanced biopsy was typically performed with breast MRI. When compared to MRI-biopsy guided therapy, the potential benefits of Contrast Enhanced Spectral Mammography (CESM) biopsy include shortened procedure time, improved patient comfort, and reduced cost for patients.

"The waiting list for MRI-guided biopsy can be as long as several weeks. With CESM guided biopsies, we can schedule patients in less than one week after their initial CESM," said Dr. Rodrigo Alcantara, Head of Breast Imaging Section at Hospital del Mar in Spain. "This new mammography-guided biopsy techniques allows for a comfortable experience and provides women with answers quickly."

Key to this technology's application is GE Healthcare's SenoBright(TM) HD CESM, which allows clinicians to perform an entire breast exam in typically less than seven minutes with the images available immediately for a radiologist to review.[3] By highlighting areas of unusual blood flow to help localize lesions that need to be biopsied, CESM biopsy - Serena Bright(TM) - can help improve radiologists' diagnostic confidence.

"Now more than ever, it is critical we put the comfort of patients first and get them answers as fast as possible. We are proud to announce this FDA clearance during a time our customers need this type of innovation the most," said Agnes Berzsenyi, President and CEO of Women's Health at GE Healthcare. "We look forward to bringing this technology to the market in the upcoming months and hope it can help improve breast cancer outcomes for women during this time of uncertainty."

*Not yet commercially available.

###

About GE Healthcare:

GE Healthcare is the $16.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

Follow us on Facebook, LinkedIn, Twitter and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

Media Contact:

Kate Rodgers

Katlynn.rodgers@ge.com

+1 617-872-1214

.

(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

All news about GENERAL ELECTRIC COMPANY
08/03CATALYZE THIS : How 400 Engineers Put Their Heads Together And Reinvented The Tu..
PU
08/03GENERAL ELECTRIC : GE's H-Series to power the new LMS-901; GE H80 with EEPC has ..
AQ
08/03GENERAL ELECTRIC : Standard Aero, Mint Turbines selected as preferred MRO servic..
AQ
08/03GENERAL ELECTRIC : NorthStar Medical Radioisotopes, GE Healthcare Sign Agreement..
MT
08/03GENERAL ELECTRIC : NorthStar Medical Radioisotopes and GE Healthcare Sign Exclus..
BU
08/02GENERAL ELECTRIC : Thinking about buying stock in Ever-Glory, NanoVibronix, Gene..
PR
08/02PORTLAND GENERAL ELECTRIC : UBS Adjusts Portland General Electric's Price Target..
MT
08/02GENERAL ELECTRIC : BofA Securities Adjusts General Electric's Price Target to $1..
MT
08/02GENERAL ELECTRIC : Wolfe Research Adjusts General Electric's Price Target to $13..
MT
08/02GENERAL ELECTRIC : RBC Adjusts Price Target on General Electric to $123 From $16..
MT
More news
Financials (USD)
Sales 2021 76 901 M - -
Net income 2021 175 M - -
Net Debt 2021 13 728 M - -
P/E ratio 2021 -85,3x
Yield 2021 0,32%
Capitalization 113 B 113 B -
EV / Sales 2021 1,65x
EV / Sales 2022 1,53x
Nbr of Employees 174 000
Free-Float 74,1%
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENERAL ELECTRIC COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 103,06 $
Average target price 116,95 $
Spread / Average Target 13,5%
EPS Revisions
Managers and Directors
H. Lawrence Culp Chairman & Chief Executive Officer
Carolina Dybeck-Happe Chief Financial Officer & Senior Vice President
Victor Abate Chief Technology Officer & Senior Vice President
Nancy Anderson Chief Information Officer & Vice President
James S. Tisch Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GENERAL ELECTRIC COMPANY19.28%113 125
BERKSHIRE HATHAWAY INC.21.82%644 138
HONEYWELL INTERNATIONAL INC.9.38%160 621
SIEMENS AG14.75%127 753
3M COMPANY15.01%116 324
ILLINOIS TOOL WORKS INC.13.12%72 849